NightWare and Cardiovascular Health in Veterans With PTSD
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Aurora, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 125 people, planned
- Started
- 10 Sept 2025
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- NightWare
- Record updated
- 8 October 2026
Who can take part
- Age
- 22 years to 88 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (22)Hide the full registry criteria
Who can take part
- Diagnosis of Post-traumatic stress disorder (PTSD) via American Psychiatric Association PTSD diagnostic criteria in the fifth edition of its Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
- Self-report having repetitive nightmares contributing to disrupted sleep
- Resting blood pressure (BP, <160/100 millimeters of mercury (mmHg)
- Fasted glucose <126 milligrams per deciliter (mg/dL)
- Poor overall sleep quality as indicated by a Pittsburgh Sleep Quality Index (PSQI) score 6 or higher
- Epworth Sleepiness Scale (ESS): Question #8 score above "0" will prompt an additional question: Do you drive ("get behind the wheel") when you are drowsy? The answer must be "No" to be enrolled in the study due to safety concerns
- Wireless Internet and two power outlets in sleeping location
- Willingness not to use any other application which collects heart rate data on the phone and watch that is used for NightWare
Who cannot take part
- Unstable medical condition (e.g., uncontrolled hypertension or active Cardiovascular disease (CVD) or cancer)
- Active infection (note, anyone with an active infection would become eligible once the infection has ended)
- Current history (past 3 months) of substance (excluding marijuana) or alcohol abuse per the SCID-5. Adults with past substance or alcohol use disorders will be allowed to participate
- Diagnosis of active disorder of arousal from non-rapid eye movement sleep, rapid eye movement sleep behavior disorder, or narcolepsy
- Diagnosis or suspicion of dementia
- Seizure disorder
- Participants experiencing severe cognitive impairment or current psychiatric symptoms of such severity that would preclude participation (e.g., active psychosis, imminently suicidal)
- Thyroid dysfunction, defined as an ultrasensitive thyroid stimulating hormone (TSH)<0.5 or >5.0 milliunits per liter (mU/L); volunteers with abnormal thyroid stimulating hormone (TSH) values will be re-considered for participation in the study after follow-up evaluation by the Primary Care Provider (PCP) with initiation or adjustment of thyroid hormone replacement; or other problems that would interfere with participation in the study
- Use of insulin or sulfonylureas
- Pregnancy or currently breast feeding
- Participants will be excluded if they report elevated acute risk for suicidal self-directed violence warranting immediate hospitalization (e.g., suicidal ideation with intent, evaluated by the Columbia-Suicide Severity Rating Scale [C-SSRS])
- Shift workers (due to circadian rhythm disruption)
- Nocturia that causes awakening from sleep
- Known sleep walking or acting out dreams (contraindication to NightWare (NW) use)
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
This trial is currently available in United States.
- Rocky Mountain Regional VA Medical Center, Aurora, COAurora, United StatesContact: Claire Cox, BSTaking people
About the trial
What the trial wants to find out
The purpose of this study is to learn more about the effectiveness of a prescription wrist-wearable device called NightWare (NW) on improving sleep in Veterans with nightmares related to posttraumatic stress disorder (PTSD). The investigators also want to learn whether it improves cardiovascular health among this population.
The 2 groups in the trial
- NightWare activeTreatment being tested
Intervention with NightWare Therapeutic System
Treatment: NightWare
- NightWare ShamSham treatment, for comparison
NightWare app disabled; device will not deliver an intervention
Treatment: NightWare
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Improving Cardiovascular Health in Veterans With PTSD by Treating Trauma-Related Nightmares With NightWare
- Criteria questions
- Built from NCT06419959, who can take part
- Record updated
- 8 October 2026